Full-Time

IVF Sales Specialist

Posted on 9/26/2024

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions provider

Biotechnology
Healthcare

Compensation Overview

$165k - $185kAnnually

+ Commission

Senior

Houston, TX, USA + 3 more

More locations: Austin, TX, USA | San Antonio, TX, USA | Phoenix, AZ, USA

Category
Field Sales
Sales & Account Management
Required Skills
Sales
Requirements
  • Bachelor’s degree or equivalent in medical or biological sciences is required (clinical diagnostics preferred)
  • Proficient in Microsoft Office
  • Experience with CRM systems and sales data tracking systems
  • Previous business experience in product demonstration, installation, and training
  • Minimum of five years in medical sales and three years of sales experience in IVF clinics (preferably in laboratory sales) or minimum of five years’ employment in clinical IVF.
  • In-­‐depth IVF knowledge and understand the workflow in an IVF setting
  • Proven track record of success in establishing new market and new products and increasing revenue quickly.
  • Strong presentation skills -­‐ proficient in delivering clinically relevant presentations to physicians and clinical staff.
  • Background in medical or biological sciences (clinical diagnostics preferred)
Responsibilities
  • Responsible for geography specific sales activities to drive market adoption and business growth within the IVF sector
  • Increasing revenue and driving market development through direct sales to individual IVF Centers.
  • Sales efforts include effective prospecting, cultivating and maintaining key relationships,
  • Creating and implementing a strategic business plan to grow revenue quickly in your geography.
  • Sales efforts will focus on currently marketed products and new product launches.
  • Contract negotiations to drive sales
  • Multi-state field travel

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera differentiates itself by offering specialized tests like the Signatera ctDNA test and Panorama NIPT for prenatal screening, along with genetic counseling services. The company's goal is to enhance patient care through accurate testing and personalized guidance.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

9%

1 year growth

25%

2 year growth

66%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased demand for liquid biopsy techniques boosts Natera's cfDNA testing solutions.
  • Telehealth expansion aligns with Natera's remote genetic counseling services.
  • Growing personalized medicine trend enhances relevance of Natera's ctDNA tests.

What critics are saying

  • Hindenburg report alleges deceptive sales practices, risking legal challenges and reputational damage.
  • New Prospera Heart features may face slow adoption by healthcare providers.
  • Fetal RhD NIPT demand may decline post-RhIg shortage, impacting revenue.

What makes Natera unique

  • Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
  • Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
  • Fetal RhD NIPT test addresses RhIg shortage, offering early fetal RhD status detection.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

INACTIVE